<DOC>
	<DOCNO>NCT01663363</DOCNO>
	<brief_summary>The purpose clinical trial demonstrate wavefront-guided LASIK safe effective correction myopic refractive error .</brief_summary>
	<brief_title>Safety Effectiveness Wavefront-Guided LASIK Corrections Myopic Refractive Errors</brief_title>
	<detailed_description />
	<mesh_term>Refractive Errors</mesh_term>
	<criteria>18 year age great Best Spectacle Corrected Visual Acuity ( BSCVA ) 20/20 well Uncorrected visual acuity ( UCVA ) 20/40 bad Less 0.75D difference cycloplegic manifest refraction sphere . Demonstration refractive stability Anticipated postoperative stromal bed thickness least 250 micron Willing capable return followup examination duration study . Women pregnant , breastfeeding , intend become pregnant course study Concurrent use topical systemic medication may impair heal History medical condition could affect wound heal History prior intraocular corneal surgery , active ophthalmic disease , ocular abnormality Evidence keratoconus , corneal irregularity , abnormal topography operative eye ( ) Known sensitivity inappropriate responsiveness medication use postoperative course</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>refractive</keyword>
	<keyword>LASIK</keyword>
</DOC>